Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...

Rakovina Therapeutics Inc. , a biopharmaceutical company advancing cancer therapies based on DNA-damage response technologies, announces continued advancement of its AI-driven drug discovery program.

The global 3D cell culture market is poised for exceptional expansion, with industry experts forecasting a substantial growth from USD 1.26 billion in 2023 to an estimated USD 3 billion by 2033. This ...

The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

Abstract Autophagy is a crucial quality control mechanism that degrades damaged cellular components through lysosomal fusion with autophagosomes ...

IR700 is being investigated in several other therapeutic modalities targeting diseases such as ocular melanoma and bladder cancer Rakuten Medical strengthens its technology platform and business ...

For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many ...

In the Phase II MAIA lung cancer trial, THIO improved patients’ overall survival when taken in combination with Libtayo.

SEOULTECH researchers develop Kombucha SCOBY bioink - enabling the creation of multilayer, self-standing structures with high resolution.

"Our prefabricated nanocellulose hydrogel network from symbiotic culture of bacteria and yeast has the potential to be used as a platform bioink for in vivo tissue engineering by loading all types of ...

This study presents a kombucha-derived bioink and digital biopen, advancing in vivo tissue engineering with efficient, ...